Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Bullboard Posts
Comment by Jasonthehumbleon Mar 25, 2020 1:18pm
80 Views
Post# 30846146

RE:RE:Unreal

RE:RE:Unreal You keep giving excuses but this thing has been a dead dog since $15...You guys said it is good and will recover all the way down....I have been patient but enough is enough. I am sick of this stupid stupid stock. It is a piece of dog poo that I have been holding since 2008 and it hasnt gone anyhwere. blah blah FDA approval doesnt mean anything if it does not reflect the stock price.....I hear the blind loyalist of THTX like SPECO and WINO and JIM saying that this thing will set off like rocket fuel blah blah...omg no...it is still dropping and it's going literally to $0. I have literally no more patience with THTX.




Wino115
 - (3/25/2020 12:19:42 PM) 
RE:Unreal 
Nothing handcuffs you. You do realize the movements in the vast majority of stocks, including THTX, are completely macro-event driven at this point. You could argue some of the hospitality, discretionary,etc.. are warranted and some of the upside stocks like Everbridge may be warranted.  But the others are the beta risk of the oveall market, not stock-specific.  You are allowed to ignore daily stock prices too.  Once there's actual fundamental news on a stock, it will likely filter in to the valuation and provide some footing (either up or down) based on how that information affects the future value of assets and cash flows. I would guess as more and more companies see the effects of the shutdown you'll get a slew of profit warnings. From SPCeo's last sales update, it sounds like they may have some lightness they will talk about, but it's not like a hotel company or anything. And as we all know, the big news is developments with the FDA which is still 1H timeframe and the ability of SV to add a bit to revenues.  The latter likely won't be happening as I doubt their sales force is calling on doctors and clinics. So don't expect any stock-specific movements until the April earnings, May annual (probably a virtual meeting now - maybe we can all log in and watch it finally!) and then tracking the FDA questions and their responses to the extent they disclose this with us.  Those would be information events that would affect the stock specifically.  All this is the high beta response of an illiquid small cap to the likely recession we will see for the rest of the year -- not THTX related at all.

Bucknelly21 wrote:I can't wait till the day I say goodbye to thtx lol 

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse